Dengue Antivirus

摘要

To provide a recombinant vaccinia virus and the like as a dengue virus vaccine that can be used as a therapeutic or prophylactic agent in clinical practice. The recombinant vaccinia virus according to the present invention is characterized in that it contains all or part of a cDNA encoding a non-structural protein derived from dengue virus and an expression promoter.